212 results
Search Results
2. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes
3. Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam
4. Involvement of biogenic amines in drug-induced aggressive pecking in chicks
5. A quantitative approach to the initial clinical trial of tricyclic antidepressants: A comparison of Leo 640 and nortriptyline
6. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
7. Neurological activities of lapachol and its furano derivatives from Kigelia africana
8. Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task
9. A depressive phenotype induced by Bacille Calmette Guérin in ‘susceptible’ animals: sensitivity to antidepressants
10. Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study
11. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study
12. Persistent effects of prior chronic exposure to corticosterone on reward-related learning and motivation in rodents
13. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose
14. Post-extinction fluoxetine treatment prevents stress-induced reemergence of extinguished fear
15. Gender-dependent effects of fluoxetine on selected biochemical parameters in guinea pigs
16. Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors
17. Nortriptyline for treating enuresis in ADHD—a randomized double-blind controlled clinical trial
18. Antidepressants and the risk of abnormal bleeding during spinal surgery: a case–control study
19. Antidepressant activity of carbamates and urea derivatives
20. Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder
21. Regioselective synthesis and evaluation of 3-alkylidene-1, 3-dihydroisobenzofurans as potential antidepressant agents
22. Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
23. Pricing dynamics and product quality: the case of antidepressant drugs
24. Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice
25. Behavioral and molecular evidence for psychotropic effects in l-theanine
26. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies
27. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults
28. New users of antidepressant medications: first episode duration and predictors of discontinuation
29. Synthesis and antidepressant-like action of N-(2-hydroxyethyl) cinnamamide derivatives in mice
30. Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness
31. Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging
32. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
33. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression
34. Infant maternal separation impairs adult cognitive performance in BALB/cJ mice
35. Use of Antidepressant Medications and Risk of Fracture in Older Women
36. CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy
37. Short-term NK1 receptor antagonism and emotional processing in healthy volunteers
38. Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear
39. Electrospray ionization-ion mobility spectrometry as a detection system for three-phase hollow fiber microextraction technique and simultaneous determination of trimipramine and desipramine in urine and plasma samples
40. The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients
41. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences
42. Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram
43. Synthesis and biological evaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives as antidepressant, anxiolytics and anticonvulsant agents
44. Patients’ attitudes toward side effects of antidepressants: an Internet survey
45. Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John’s wort extract (STW 3-VI) and fluoxetine
46. Inflammatory Biomarkers and Depression
47. The role of serotonin receptor subtypes in treating depression: a review of animal studies
48. Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion
49. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse
50. Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.